Compare ASRT & ORIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASRT | ORIQ |
|---|---|---|
| Founded | 1995 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 88.4M |
| IPO Year | 2004 | N/A |
| Metric | ASRT | ORIQ |
|---|---|---|
| Price | $23.43 | $10.28 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 421.1K | 49.5K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $118,713,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.60 | $10.01 |
| 52 Week High | $23.46 | $10.28 |
| Indicator | ASRT | ORIQ |
|---|---|---|
| Relative Strength Index (RSI) | 86.13 | 66.74 |
| Support Level | $0.70 | $10.17 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.18 | 0.01 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 98.48 | 100.00 |
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Origin Investment Corp I is a blank check company.